VWM
JAZZ icon

Venturi Wealth Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Venturi Wealth Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,698
Closed -$335K – 578
2025
Q1 		$335K Sell
2,698
-27
-1% -$3.52K 0.02% 417
2024
Q4 		$336K Buy
2,725
+1,899
+230% +$224K 0.02% 420
2024
Q3 		$92K Buy
826
+704
+577% +$77.1K ﹤0.01% 584
2024
Q2 		$13K Buy
122
+4
+3% +$440 ﹤0.01% 1046
2024
Q1 		$14.2K Buy
+118
New +$14.5K ﹤0.01% 834
2023
Q4 		– Sell
-13
Closed -$1.68K – 1393
2023
Q3 		$1.68K Buy
+13
New +$1.73K ﹤0.01% 1207

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Venturi Wealth Management's JAZZ Position: Q2 2025 in Review

Venturi Wealth Management sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2025, closing a stake of 2,698 shares — an estimated $335K sold.

Venturi Wealth Management first reported a position in JAZZ in Q3 2023 and held it in 6 quarters. The position peaked at $336K in Q4 2024. 501 funds tracked by Wall St. Rank hold JAZZ as of Q2 2025.

  • Venturi Wealth Management reported no remaining Jazz Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Venturi Wealth Management sold 2,698 Jazz Pharmaceuticals shares in Q2 2025, an estimated $335K.
  • Venturi Wealth Management first reported a position in Jazz Pharmaceuticals in Q3 2023 and held it in 6 quarters.
  • Venturi Wealth Management's Jazz Pharmaceuticals position peaked at $336K in Q4 2024.
  • 501 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2025.

Based on Venturi Wealth Management's 13F filing for Q2 2025, filed 23 Jul 2025.